Abstract
Activation of Toll-like receptors (TLRs) via a nuclear protein released from dying cells, high-mobility group box-1 (HMGB1) protein, leads to chronic epilepsy in rat models and in human epileptic tissue. Blocking this inflammatory pathway may constitute a new antiepileptic treatment strategy ( pages 413–419 ).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
